Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Capitol Capsule: Biomedical innovation: This stuff is hard

This article was originally published in Scrip

Executive Summary

After decades of pursuing drug development in much the same way, one thing the biopharmaceutical industry has learned is "this stuff is hard" and it oftentimes has been a rough road going it alone, said Dr Mark McClellan, a senior fellow and director of the Health Care Innovation and Value Initiative at the Washington-based think tank the Brookings Institution.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC028111

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel